Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Governors Group Calls For Greater Medicaid Rebates

This article was originally published in The Pink Sheet Daily

Executive Summary

Higher rebate payments from drug manufacturers should be one element of Medicaid reform, a new “interim” policy from the National Governors Association states. NGA’s executive committee also endorses changes to AWP-based reimbursement and establishment of tiered copays.

You may also be interested in...



Medicaid Commission Suggests $6.3 Bil. In Rx Savings

HHS panel urges changes in pharmacy reimbursement to an average manufacturer price-based model and greater flexibility in implementing tiered co-pays.

Medicaid Commission Suggests $6.3 Bil. In Rx Savings

HHS panel urges changes in pharmacy reimbursement to an average manufacturer price-based model and greater flexibility in implementing tiered co-pays.

Three-State Drug Purchasing Pool Approved By HHS

Louisiana, Maryland and West Virginia will combine their purchasing power to obtain better drug prices for Medicaid and other state programs. It is the second multi-state pool approved by HHS.

Topics

UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel